Sound Mind launches its third mutual fund

Back to TopCommentsE-mailPrintBookmark and Share

A Columbus, Ind.-based firm has launched a new mutual fund with hopes of catering to conservative investors.

The Securities and Exchange Commission on Thursday approved the Sound Mind Balanced Fund, the third component in the Sound Mind Investing Fund family.

It includes 60 percent equity investments using the same strategy that’s a hallmark of the firm. But it also will include 40 percent bonds to provide balance for more risk-averse investors.

Sound Mind is among just a handful of mutual fund families based or managed in the state.

Its equity-investment strategy differs from its counterparts. Instead of betting on stocks, Sound Mind invests in other mutual funds that are performing well, based on relatively short-term metrics. It sticks with them until their performance slips out of the top quartile, based on returns over three-,six- and nine-month periods.

The approach was initially developed as the driving philosophy in a Christian financial newsletter, a separate entity called the Sound Mind Investing newsletter.

It has paid off this year. As of Tuesday, Sound Mind's flagship fund, comprised entirely of equity investments, was up 18 percent year-to-date. But it can force short-term pain, as fund managers must follow the prescribed formula, rather than dropping funds as soon as they begin performing poorly.

The new fund will incorporate the same strategy—termed “upgrading”—into its equity component. Sound Mind has brought on another Columbus firm, Reams Asset Management Co., to serve as advisers on the bond portion of the fund.

Fred Beerwart, Sound Mind’s chief compliance officer, said the new fund meets a need for the fund’s current investors, many of whom read the newsletter and are advised to diversify their portfolios.

“The 60-40 balanced approach does fit hand in glove with what our client base has been taught,” he said.


Post a comment to this story

We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
You are legally responsible for what you post and your anonymity is not guaranteed.
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
Subscribe to IBJ
  1. OK Larry, let's sign Lance, shore up the PG and let's get to the finals.

  2. A couple of issues need some clarification especially since my name was on the list. I am not sure how this information was obtained and from where. For me, the amount was incorrect to begin with and the money does not come to me personally. I am guessing that the names listed are the Principal Investigators (individual responsible for the conduct of the trail) for the different pharmaceutical trials and not the entity which receives the checks. In my case, I participate in Phase II and Phase III trials which are required for new drug development. Your article should differentiate the amount of money received for consulting, for speaking fees, and for conduct of a clinical trial for new drug development. The lumping of all of these categories may give the reader a false impression of physicians just trying to get rich. The Sunshine Law may help to differentiate these categories in the future. The public should be aware that the Clinical Trial Industry could be a real economic driver for Indiana since these revenues supports jobs and new job creation. Nationally, this account for 10-20 billion which our State is missing out on to a large degree. Yes, new drug and technology development has gotten most of the attention (e.g. CTSI, BioCrossroads, etc.) However, serious money is being left on the table by not participating in the clinical trials to get those new drugs and medical devices on the market!!!! I guess that this is not sexy enough for academia.

  3. The address given for the Goldfish Swim Club is the Ace Hardware, is it closing?

  4. Out of state management and ownership. If Kite controlled it, everything would be leased. Of course, due to the roundabout, there is limited access to the south side of 116th now also. Just have to go down to the light.

  5. Hey smudge, You're opposed to arresting people for minor crimes? Sounds great! We should only focus on murders and such, right? Let's stand around and wait until someone shoots someone before we act. Whatever we do, we should never question anyone, frisk anyone, or arrest anyone unless they are actively engaged in shooting or stabbing. Very sound!